Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Afnan Aljaloud"'
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundSemaglutide is a glucagon-like peptide-1 receptor agonists (GLP-1-RAs) approved for the treatment of type 2 diabetes mellitus (T2DM) at doses up to 1 mg. The results from randomized control trials and real-world studies revealed that weekly
Externí odkaz:
https://doaj.org/article/10aa1dd5493540a39738e96a3c31c14f
